Disclosures: Khalid Aloum: Nothing to Disclose, Amr Dokmak: Nothing to Disclose, Wendy Tatiana Garzon-Siatoya: Nothing to Disclose, Abdellatif Ismail: Nothing to Disclose, Camelia Ciobanu: Nothing to Disclose, Jeeva Jaganathan: Nothing to Disclose, Praneeth Bandaru: Nothing to Disclose, Ali Wakil: Nothing to Disclose, Arnold Nongmoh Forlemu: Nothing to Disclose, Vijay Bhaskar Reddy Gayam: Nothing to Disclose, Vikash Kumar: Nothing to Disclose, Raissa Nana Sede Mbakop: Nothing to Disclose, Lisnaldy Ramirez: Nothing to Disclose, Manasa Ginjupalli: Nothing to Disclose, Denzil Etienne: Nothing to Disclose, Nithan Narendra: Nothing to Disclose, Madhavi Reddy: Nothing to Disclose 1055 UTILIZING FIB-4 AND TRANSIENT ELASTOGRAPHY TO DIAGNOSE STEATOTIC LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: QUALITY IMPROVEMENT PROJECT AT A VETERANS AFFAIRS RESIDENT CLINIC Nimmy Thomas 1 Christina Stull 1 Holli Sadler 2 , 1 UT Austin Dell Medical School, 2 Central Texas Veterans Affairs Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality

Ngoi ra, glutathione trong sn phm cn gip tng min dch, o thi c t kim loi ra khi c th, h tr t chy m tha, duy tr vc dng
They are pure active ingredients, pharmaceutical quality formulations meticulously selected
1169 / 2011, Annex II